MUC16 and cancer: Inflammatory stimuli such as oxidative stress and treatment with cytokines IFNγ, IL-1α, TNFα have also been found to alter the glycosylation pattern of MUC16 in pancreatic cancer cells (39), suggesting that MUC16 may play a key role in promoting inflammatory signaling in cancer.